D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.2B |
| 2 |
Boston Scientific
BSX
|
+$1.05B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$934M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$924M |
| 5 |
JPMorgan Chase
JPM
|
+$922M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.2B |
| 2 |
NVIDIA
NVDA
|
+$1.58B |
| 3 |
Palantir
PLTR
|
+$901M |
| 4 |
Netflix
NFLX
|
+$883M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$805M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.42% |
| 2 | Technology | 18.55% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 8.5% |
| 5 | Healthcare | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
876
JD.com
JD
$36.2B
| $28.8M | 0.02% |
974,453
+58,669
| +6% | +$1.66M |
2023 Q3
10 quarters
|
|
877
Main Street Capital
MAIN
$5.03B
| $28.8M | 0.02% |
543,325
+264,791
| +95% | +$15.7M |
2025 Q1
4 quarters
|
|
878
BellRing Brands
BRBR
$990M
| $28.8M | 0.02% |
1,788,251
-712,772
| -28% | -$14.4M |
2022 Q4
13 quarters
|
|
879
Amdocs
DOX
$6.16B
| $28.7M | 0.02% |
439,392
+242,036
| +123% | +$17.7M |
2013 Q2
51 quarters
|
|
880
CALL
Texas Instruments
TXN
$263B
| $28.7M | 0.02% |
147,700
-76,800
| -34% | -$15.5M |
2022 Q2
15 quarters
|
|
881
CALL
EchoStar
ECHO
$26.6B
| $28.6M | 0.02% |
244,700
-95,800
| -28% | -$11M |
2025 Q3
2 quarters
|
|
882
Viking Holdings
VIK
$36.7B
| $28.6M | 0.02% |
389,362
+145,784
| +60% | +$10.7M |
2025 Q2
3 quarters
|
|
883
Cullen/Frost Bankers
CFR
$9.42B
| $28.6M | 0.02% |
208,509
+59,879
| +40% | +$8.27M |
2025 Q1
4 quarters
|
|
884
CALL
Petrobras
PBR
$164B
| $28.5M | 0.02% |
1,375,400
+1,140,400
| +485% | +$18.2M |
2025 Q2
3 quarters
|
|
885
PUT
Nutrien
NTR
$33.3B
| $28.5M | 0.02% |
378,000
-32,000
| -8% | -$2.28M |
2020 Q1
24 quarters
|
|
886
Ziff Davis
ZD
$1.98B
| $28.4M | 0.02% |
675,898
+27,768
| +4% | +$1.02M |
2022 Q1
16 quarters
|
|
887
Dentsply Sirona
XRAY
$1.7B
| $28.2M | 0.02% |
2,432,719
-2,002,025
| -45% | -$25M |
2018 Q1
32 quarters
|
|
888
Iovance Biotherapeutics
IOVA
$6.57B
| $28.1M | 0.02% |
8,016,353
+4,186,558
| +109% | +$13.4M |
2020 Q3
22 quarters
|
|
889
Insulet
PODD
$9.58B
| $28M | 0.02% |
133,597
+105,593
| +377% | +$26.5M |
2025 Q4
1 quarter
|
|
890
Gilead Sciences
GILD
$183B
| $28M | 0.02% |
200,919
+8,214
| +4% | +$1.15M |
2021 Q4
17 quarters
|
|
891
iShares US Aerospace & Defense ETF
ITA
$11.9B
| $27.9M | 0.02% |
+127,774
| New | +$29.9M |
2026 Q1
0 quarters
|
|
892
Harmonic Inc
HLIT
$1.15B
| $27.9M | 0.02% |
3,101,896
-298,579
| -9% | -$2.97M |
2021 Q2
19 quarters
|
|
893
CALL
SolarEdge
SEDG
$2B
| $27.9M | 0.02% |
545,600
-667,000
| -55% | -$25.1M |
2019 Q3
26 quarters
|
|
894
Clearway Energy Class C
CWEN
$3.69B
| $27.8M | 0.02% |
706,632
-504,383
| -42% | -$18.8M |
2025 Q3
2 quarters
|
|
895
CALL
Charter Communications
CHTR
$12.2B
| $27.7M | 0.02% |
128,500
+90,000
| +234% | +$19.5M |
2014 Q2
47 quarters
|
|
|
896
PUT
JPMorgan Chase
JPM
$881B
| $27.7M | 0.02% |
94,200
-2,300
| -2% | -$698K |
2013 Q2
51 quarters
|
|
|
897
CALL
Nutrien
NTR
$33.3B
| $27.7M | 0.02% |
366,700
+8,000
| +2% | +$570K |
2021 Q4
17 quarters
|
|
898
Duolingo
DUOL
$6.55B
| $27.6M | 0.02% |
280,428
+243,093
| +651% | +$30M |
2022 Q2
15 quarters
|
|
899
MKS Inc
MKSI
$16.7B
| $27.6M | 0.02% |
+120,173
| New | +$27.2M |
2026 Q1
0 quarters
|
|
900
PUT
Coupang
CPNG
$27.2B
| $27.6M | 0.02% |
1,459,900
+1,426,000
| +4,206% | +$27.9M |
2025 Q4
1 quarter
|
|
Similar funds
D.E. Shaw & Co's Q1 2026 Portfolio in Review
As of Q1 2026, D.E. Shaw & Co held 5,226 positions worth $166B, down 8.8% from $182B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co withdrew a net $5.92B in Q1 2026, closing 756 positions and reducing 1,922 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $805M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, down from 36% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in Venture Global Inc worth $211M.
- D.E. Shaw & Co's largest Q1 2026 buy was Venture Global Inc: 13,410,074 shares worth $211M.
- D.E. Shaw & Co added most to Broadcom in Q1 2026, an estimated $1.2B increase.
- D.E. Shaw & Co's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.2B.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $805M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $166B portfolio in Q1 2026.
- D.E. Shaw & Co opened 685 new positions and closed 756 in Q1 2026.
- D.E. Shaw & Co's portfolio value fell 8.8% quarter-over-quarter to $166B.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.